DMRA Damora Therapeutics, Inc.

NASDAQ
$30.06

Damora Therapeutics, Inc. (DMRA) Seasonality

What this stock has historically done over the three months following this point in the calendar year, measured against every other three-month stretch on record.

Not enough price history for DMRA to build a seasonal study.